BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24680448)

  • 1. Improvement in clinical TNM staging documentation within a prostate cancer quality improvement collaborative.
    Filson CP; Boer B; Curry J; Linsell S; Ye Z; Montie JE; Miller DC
    Urology; 2014 Apr; 83(4):781-6. PubMed ID: 24680448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in prostate cancer detection rates in a statewide quality improvement collaborative.
    Riedinger CB; Womble PR; Linsell SM; Ye Z; Montie JE; Miller DC; Lane BR;
    J Urol; 2014 Aug; 192(2):373-8. PubMed ID: 24582538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer.
    Miller DC; Murtagh DS; Suh RS; Knapp PM; Schuster TG; Dunn RL; Montie JE
    J Urol; 2011 Sep; 186(3):844-9. PubMed ID: 21788043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancer.
    Ross I; Womble P; Ye J; Linsell S; Montie JE; Miller DC; Cher ML
    J Urol; 2015 Apr; 193(4):1159-62. PubMed ID: 25444985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a urological surgery quality collaborative.
    Miller DC; Murtagh DS; Suh RS; Knapp PM; Dunn RL; Montie JE
    J Urol; 2010 Dec; 184(6):2485-90. PubMed ID: 20961582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer.
    Hurley P; Dhir A; Gao Y; Drabik B; Lim K; Curry J; Womble PR; Linsell SM; Brachulis A; Sexton DW; Ghani KR; Denton BT; Miller DC; Montie JE;
    J Urol; 2017 May; 197(5):1222-1228. PubMed ID: 27889418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
    J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Use of Prostate Biopsy Among Men with Limited Life Expectancy in a Statewide Quality Improvement Collaborative.
    Abdollah F; Ye Z; Miller DC; Linsell SM; Montie JE; Peabody JO; Ghani KR;
    Eur Urol; 2016 Nov; 70(5):854-861. PubMed ID: 27113032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative quality improvement.
    Luckenbaugh AN; Miller DC; Ghani KR
    Curr Opin Urol; 2017 Jul; 27(4):395-401. PubMed ID: 28459792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between urologists in the United States and Canada in the approach to prostate cancer.
    Fleshner N; Rakovitch E; Klotz L
    J Urol; 2000 May; 163(5):1461-6. PubMed ID: 10751858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pT2 subdivisions in the TNM staging system for prostate cancer.
    Hong SK; Han BK; Chung JS; Park DS; Jeong SJ; Byun SS; Choe G; Lee SE
    BJU Int; 2008 Nov; 102(9):1092-6. PubMed ID: 18671786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.
    Miller DC; Litwin MS; Sanda MG; Montie JE; Dunn RL; Resh J; Sandler H; Wei JT
    Cancer; 2003 Mar; 97(6):1428-35. PubMed ID: 12627506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.
    Luckenbaugh AN; Auffenberg GB; Hawken SR; Dhir A; Linsell S; Kaul S; Miller DC;
    J Urol; 2017 Mar; 197(3 Pt 1):621-626. PubMed ID: 27663459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.
    van Oort IM; Witjes JA; Kok DE; Kiemeney LA; Hulsbergen-Van De Kaa CA
    BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative.
    Womble PR; Dixon MW; Linsell SM; Ye Z; Montie JE; Lane BR; Miller DC; Burks FN;
    J Urol; 2014 Jun; 191(6):1787-92. PubMed ID: 24345442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
    Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A
    Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Care in Urology and the Michigan Urological Surgery Improvement Collaborative.
    Montie JE; Linsell SM; Miller DC
    Urol Pract; 2014 Jul; 1(2):74-78. PubMed ID: 37537830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical decision making in upper aerodigestive tract cancer patient follow-up.
    Virgo KS; Paniello RC; Johnson MH; Clemente MF; Johnson FE
    Int J Oncol; 2002 Nov; 21(5):1101-9. PubMed ID: 12370761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.
    Blayney DW; McNiff K; Hanauer D; Miela G; Markstrom D; Neuss M
    J Clin Oncol; 2009 Aug; 27(23):3802-7. PubMed ID: 19487377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.